Apple’s Glass-Centric 20th-Anniversary iPhone Remains on Track for 2027
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (7)
- Apple stock sinks as hopes that new CEO John Ternus will launch a high-end, ‘all-glass’ iPhone are shattered Fortune · 14d ago
- Apple Still Planning 'Glass-Centric' iPhone Redesign for 2027 MacRumors · 14d ago
- New rumor counters that all-glass 20th-anniversary iPhone will still happen AppleInsider · 14d ago
- Jefferies downgrades Apple stock to sell over canceled glass iPhone Yahoo Finance · 14d ago
- Apple Cut at Jefferies on iPhone Worries as Sell Ratings Pile Up Yahoo Finance · 14d ago
- Stock price overreaction? Apple is reportedly still moving forward with its glass-bodied iPhone but has abandoned the all-glass design. Moomoo · 14d ago
- Jefferies downgrades Apple stock to sell over canceled glass iPhone qz.com · 14d ago broke it first
From around our network
Related trends
Dick's Sporting Goods misses revenue expectations, citing 'challenging' footwear market
Dick’s Sporting posts $17.22 B FY25 sales yet misses forecasts as a tough footwear market tests its Foot Locker integration.
Lego posts record first-half revenue, CEO touts strong sales at high-end and value pricing
Lego's record first‑half revenue, driven by World Cup and premium sets, spotlights a booming toy market.
Druckenmiller, Bessent’s Early Mentor, Calls Bond Buys a Mistake
Stanley Druckenmller brands the U.S. Treasury’s latest bond buyback a credibility‑killing mistake, sparking fresh market debate.
Starbucks’ Pumpkin Spice Latte Is Back, Along With 6 All-New Drinks—and We Tried Them First
Starbucks rolls out its 2026 Pumpkin Spice Latte comeback alongside six brand‑new fall drinks, sparking immediate consumer buzz.
Shooting involving at least one officer after disturbance at Lodi McDonald's, police say
A police shooting following an armed disturbance inside a Lodi McDonald's has drawn heavy local media attention.
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.